Details of the Drug

General Information of Drug (ID: DMOWINT)

Drug Name

Reloxaliase

Synonyms

ALLN-177

Indication

Disease Entry	ICD 11	Status	REF
Hyperoxaluria	5C51.2	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Protein

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Oxalate absorption (Oxalate absor)	TTMDQIJ	NOUNIPROTAC	Replacement	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03847090) Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria (URIROX-2). U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Allena Pharmaceuticals.